recombin
protein
subunit
vaccin
formul
use
defin
protein
antigen
produc
heterolog
express
system
methylotroph
yeast
pichia
pastori
becom
import
host
system
product
recombin
subunit
vaccin
although
mani
basic
element
p
pastori
express
system
well
develop
still
room
optim
protein
product
codon
bia
gene
dosag
endoplasm
reticulum
protein
fold
cultur
condit
import
consider
improv
product
recombin
vaccin
antigen
comment
current
advanc
applic
p
pastori
synthesi
recombin
subunit
vaccin
p
pastori
becom
highli
success
express
system
due
increas
popular
attribut
sever
factor
high
growth
rate
eas
genet
manipul
high
yield
express
heterolog
protein
capabl
perform
eukaryot
posttransl
modif
p
pastori
system
much
easier
perform
cheaper
cost
compar
bacteri
express
system
p
pastori
usual
produc
higher
yield
recombin
protein
less
demand
term
time
effort
rel
complex
eukaryot
system
present
p
pastori
extens
appli
commerci
product
variou
foreign
protein
vaccin
virus
divid
main
categori
live
attenu
inactivatedkil
subunit
vaccin
live
attenu
vaccin
contain
weaken
virus
still
induc
adapt
immun
respons
structur
nonstructur
protein
replic
live
attenu
virus
suffici
restrict
avoid
patholog
effect
although
live
attenu
vaccin
could
induc
strong
longlast
immun
respons
might
revers
virul
wildtyp
strain
caus
diseas
immunocompromis
individu
inactiv
kill
vaccin
rel
safe
less
effect
elicit
protect
immun
respons
inactiv
kill
vaccin
may
present
product
problem
commerci
scale
term
growth
viru
suffici
high
titer
econom
yield
well
hazard
contain
issu
larg
scale
growth
nonattenu
live
viru
recombin
protein
subunit
vaccin
compos
least
type
viral
antigen
produc
heterolog
express
system
recombin
protein
subunit
vaccin
significantli
secur
live
attenu
inactivatedkil
vaccin
addit
recombin
protein
subunit
vaccin
scale
costeffect
manner
compar
type
vaccin
past
decad
trend
toward
develop
subunit
vaccin
formul
contain
precis
specifi
antigen
compon
togeth
potent
adjuv
subunit
vaccin
must
efficaci
safe
easili
scale
mass
product
p
pastori
system
licens
compani
biotechnolog
pharmaceut
vaccin
food
industri
p
pastorisproduc
biopharmaceut
industri
enzym
approv
unit
state
food
drug
administr
fda
indic
p
pastori
system
wide
accept
safe
suitabl
human
use
addit
p
pastori
use
system
basic
laboratori
research
industri
manufactur
provid
effici
platform
highlevel
product
subunit
vaccin
focu
new
develop
understand
applic
p
pastori
product
recombin
subunit
vaccin
virus
gener
featur
pichia
pastori
express
system
p
pastori
express
strain
deriv
wild
type
strain
auxotroph
mutant
proteasedefici
strain
frequent
use
genom
p
pastori
contain
gene
encod
alcohol
oxidas
regard
abil
util
methanol
phenotyp
p
pastori
name
mut
c
methanol
util
widetyp
mut
methanol
util
slow
mut
methanol
util
delet
mut
c
strain
contain
intact
activ
aox
gene
character
higher
growth
rate
mut
strain
mut
strain
unabl
grow
methanol
sole
carbon
sourc
due
knockout
aox
gene
success
p
pastori
product
recombin
protein
directli
link
strong
induc
promot
gene
encod
first
enzym
methanol
util
pathway
alcohol
oxidas
promot
p
repress
glucos
glycerol
ethanol
strongli
induc
methanol
make
p
pastori
rel
tightli
control
express
system
use
p
also
hold
advantag
overexpress
recombin
protein
methanol
highli
flammabl
hazard
substanc
therefor
undesir
unsaf
use
methanol
induc
largescal
ferment
altern
induc
constitut
promot
induc
without
methanol
still
reach
high
express
level
use
product
recombin
protein
promot
glutathionedepend
enzym
formaldehyd
dehydrogenas
p
attract
altern
p
allow
regul
protein
express
via
induct
methanol
methylamin
p
transcript
effici
show
similar
regulatori
properti
p
constitut
express
eas
process
handl
avoid
use
potenti
hazard
induc
provid
continu
transcript
target
gene
promot
p
gap
provid
constitut
express
foreign
protein
glycerol
glucos
methanol
media
reach
express
level
methanolinduc
p
sever
constitut
promot
also
use
gener
recombin
protein
p
pastori
promot
phosphoglycer
kinas
p
translat
elong
factor
p
transform
host
cell
p
pastori
vector
integr
host
genom
form
stabli
express
clone
obtain
high
yield
foreign
protein
optim
clone
contain
multipl
copi
target
gene
must
determin
copi
number
assess
coloni
screen
use
enhanc
concentr
antibiot
realtim
pcr
p
pastori
system
also
highli
suitabl
largescal
growth
cultur
use
bioreactor
moreov
inexpens
growth
medium
make
p
pastori
effici
costeffect
express
system
compar
express
system
saccharomyc
cerevisia
chines
hamster
ovari
cho
cell
baculovirusinsect
cell
p
pastori
system
usual
produc
higher
level
heterolog
protein
eukaryot
organ
p
pastori
possess
capabl
perform
posttransl
modif
includ
proteolyt
process
protein
fold
glycosyl
foreign
protein
express
p
pastori
either
intracellular
secretori
one
import
advantag
use
p
pastori
abil
secret
high
level
activ
heterolog
protein
secretori
express
recombin
protein
requir
presenc
signal
sequenc
vector
commonli
use
secret
signal
p
pastori
cerevisia
amat
factor
leader
sequenc
amf
amf
signal
sequenc
proven
effect
direct
protein
secretori
pathway
p
pastori
report
use
amf
signal
peptid
lead
product
higher
amount
foreign
protein
use
nativ
signal
peptid
sinc
p
pastori
secret
low
level
nativ
protein
secret
heterolog
protein
constitut
major
total
protein
medium
secret
recombin
protein
medium
contribut
avoid
toxic
intracellularli
accumul
materi
well
simplifi
purif
process
current
avail
vaccin
mostli
consist
live
attenu
inactivatedkil
virus
although
vaccin
formul
shown
success
diseas
polio
erad
part
world
mani
issu
still
remain
associ
vaccin
exampl
vaccin
alway
effect
need
maintain
cool
chain
immunocompromis
peopl
live
vaccin
may
lead
sever
diseas
cost
relat
product
administr
make
vaccin
difficult
use
mass
immun
peopl
therefor
urgent
need
develop
effect
subunit
vaccin
infecti
diseas
recombin
protein
subunit
vaccin
gain
interest
recent
year
recombin
protein
subunit
vaccin
compos
small
number
microbi
compon
produc
heterolog
express
system
ensur
subunit
vaccin
welldefin
composit
compar
type
vaccin
import
advantag
subunit
vaccin
safeti
compon
contain
recombin
protein
synthet
peptid
without
involv
infecti
virus
subunit
vaccin
usual
induc
side
effect
inject
site
featur
made
subunit
vaccin
attract
vaccin
candid
ideal
subunit
vaccin
safe
stabl
immunogen
immun
individu
manufactur
purif
character
effici
inexpens
enabl
widespread
vaccin
use
develop
recombin
protein
subunit
vaccin
depend
knowledg
viral
antigen
induc
protect
immun
respons
infect
addit
protein
vaccin
usual
requir
correct
fold
induct
immun
respons
abil
produc
larg
amount
viral
antigen
vaccin
manufactur
import
subunit
vaccin
develop
largescal
product
antigen
industri
purpos
enabl
recombin
dna
technolog
recombin
viral
antigen
spontan
assembl
viruslik
particl
vlp
multiprotein
structur
without
incorpor
viral
genom
vlp
potenti
safe
subunit
vaccin
induc
immun
respons
similar
prompt
natur
viral
infect
vlp
present
repetit
highdens
display
epitop
exhibit
excel
adjuv
properti
capabl
induc
strong
immun
respons
found
vlp
stabl
consider
immunogen
purifi
protein
antigen
therefor
vlp
vaccin
consid
candid
altern
wholeviru
vaccin
present
vlp
vaccin
licens
commerci
exampl
vlpbase
vaccin
produc
yeast
glaxosmithklin
hepat
b
viru
hbv
gardasil
human
papillomaviru
hpv
current
commerci
worldwid
larg
number
vlpbase
vaccin
candid
undergo
preclin
clinic
evalu
influenza
viru
parvoviru
vlp
order
verifi
vaccin
efficaci
variou
paramet
monitor
level
antigenspecif
antibodi
immun
dose
type
immun
cell
respond
advers
effect
new
vaccin
enter
market
mani
obstacl
overcom
research
develop
often
last
decad
vaccin
market
time
antigen
composit
target
pathogen
might
adjust
vaccin
dosag
also
increas
due
lack
longterm
immun
immun
antigen
stimul
protect
immun
respons
usual
chosen
vaccin
candid
research
develop
vaccin
candid
preclin
studi
cell
cultur
tissu
anim
begin
howev
anim
experi
still
main
focu
preclin
studi
depend
type
vaccin
rout
administr
differ
anim
model
use
mice
rat
dog
primat
pharmacolog
toxicolog
effect
vaccin
candid
assess
initi
clinic
studi
nevertheless
new
vaccin
candid
usual
fail
preclin
phase
sinc
guarante
safeti
efficaci
clinic
evalu
involv
studi
effect
vaccin
candid
healthi
volunt
immunogen
efficaci
safeti
use
pichia
pastori
recombin
subunit
vaccin
develop
e
coli
wide
use
commerci
gener
approxim
biopharmaceut
product
research
laboratori
product
protein
although
e
coli
mani
advantag
product
system
gener
recombin
protein
system
often
result
inclus
bodi
format
low
yield
foreign
protein
lack
posttransl
modif
therefor
gener
declin
use
e
coli
host
cell
eukaryot
microb
offer
mani
benefit
eukaryot
host
cell
retain
advantag
microbi
among
eukaryot
microb
system
p
pastori
promis
platform
produc
variou
foreign
protein
p
pastori
capabl
synthesis
protein
form
mirror
nativ
conform
immunogen
therefor
p
pastori
wide
use
manufactur
subunit
vaccin
candid
date
multitud
recombin
subunit
vaccin
candid
success
express
p
pastori
tabl
focu
articl
p
pastorisderiv
subunit
vaccin
candid
human
virus
success
trail
p
pastorisproduc
recombin
epsteinbarr
viru
ebv
vaccin
candid
report
ebv
ubiquit
human
herpesviru
associ
develop
variou
malign
nasopharyng
carcinoma
npc
gastric
carcinoma
gc
hodgkin
lymphoma
hl
burkitt
lymphoma
bl
viral
glycoprotein
attract
candid
prophylact
vaccin
secretori
form
truncat
codon
potenti
develop
ebv
subunit
vaccin
moreov
recombin
protein
abl
induc
higher
level
specif
antibodi
synthet
peptid
ebv
nuclear
antigen
thought
promis
antigen
ebv
therapeut
vaccin
previou
studi
conduct
investig
immunogen
truncat
form
codon
synthes
p
pastori
yield
recombin
protein
p
pastori
mgl
higher
e
coli
mgl
high
immunogen
recombin
also
demonstr
elicit
strong
immun
respons
mice
howev
result
effect
enough
use
ebv
vaccin
candid
work
requir
evalu
protect
efficaci
recombin
dengu
caus
viral
serotyp
one
fastest
spread
vectorborn
diseas
envelop
domainiii
ediii
antigen
garner
much
attent
promis
vaccin
candid
dengu
p
pastori
optim
secretori
overexpress
ediii
result
suggest
casamino
acid
supplement
facilit
overexpress
p
pastori
cell
secret
ediii
reduc
proport
retain
intracellularli
purifi
ediii
antigen
could
induc
neutral
antibodi
strategi
describ
studi
enabl
fulfil
mount
demand
recombin
ediii
well
laid
direct
futur
studi
secretori
express
recombin
protein
p
pastori
outbreak
highli
pathogen
avian
influenza
brought
seriou
threat
public
health
neuraminidas
na
clone
p
pastori
recombin
protein
purifi
total
yield
purifi
rna
mgl
mice
vaccin
rna
exhibit
signific
immun
respons
result
laid
foundat
fast
costeffect
develop
vaccin
circul
newer
strain
avian
influenza
japanes
enceph
viru
jev
envelop
e
protein
express
p
pastori
glycosyl
puriti
e
protein
greater
p
pastorisproduc
recombin
e
protein
could
stimul
immun
respons
capabl
mediat
signific
protect
jev
infect
studi
might
provid
help
inform
develop
subunit
vaccin
jev
enteroviru
major
caus
pathogen
hand
foot
mouth
diseas
hfmd
highlevel
secretori
product
capsid
protein
obtain
p
pastori
approxim
mgl
recombin
could
elicit
protect
immun
respons
vaccin
mice
p
pastorisexpress
promis
vaccin
candid
industri
purpos
success
express
viral
antigen
highlight
potenti
p
pastori
develop
safe
efficaci
afford
subunit
vaccin
p
pastori
also
develop
innov
platform
product
vlp
vaccin
purpos
p
pastorisproduc
envelopebas
vlp
preserv
antigen
integr
major
neutral
epitop
also
capabl
elicit
neutral
antibodi
hpv
major
capsid
protein
selfassembl
vlp
express
heterolog
main
compon
current
avail
vaccin
cervic
cancer
howev
commerci
hpv
vaccin
expens
still
inaccess
major
popul
especi
econom
disadvantag
region
therefor
great
need
develop
altern
system
product
hpv
vaccin
provid
public
health
program
recent
report
gene
encod
optim
insert
p
pastori
express
vector
intracellular
hpv
vlp
success
produc
p
pastori
facilit
develop
hpv
vaccin
coxsackieviru
caus
hfmd
infant
children
p
pastorisderiv
vlp
could
induc
hightit
serum
antibodi
confer
complet
protect
lethal
challeng
neonat
mice
yield
vlp
mg
l
howev
vlp
yield
p
pastori
could
improv
via
optim
regulatori
element
highdens
yeast
ferment
effici
product
process
develop
use
p
pastori
vlp
contain
protein
also
report
vlp
express
high
level
total
solubl
protein
mgl
p
pastori
vlp
could
induc
neutral
antibodi
homolog
heterolog
strain
confer
protect
lethal
viru
infect
neonat
mice
hbv
surfac
antigen
hbsag
use
long
time
vaccin
candid
enhanc
method
express
purif
recombin
hbsag
vlp
p
pastori
describ
previou
studi
approxim
mg
hbsag
vlp
puriti
greater
obtain
l
cultur
broth
p
pastorisderiv
hbsagbas
vlp
could
elicit
significantli
high
hbsagspecif
igg
titer
well
strong
cellular
immun
respons
result
indic
hbsagbas
vlp
potenti
superior
vaccin
current
licens
hbv
vaccin
result
demonstr
p
pastorisproduc
vlp
repres
promis
vaccin
candid
proven
preclin
efficaci
desir
trait
manufactur
industri
scale
improv
yield
recombin
subunit
vaccin
p
pastori
import
optim
gene
sequenc
encod
target
antigen
accord
codon
bia
p
pastori
codon
optim
gene
interest
usual
result
dramat
increas
protein
express
level
p
pastori
system
exampl
yield
codonoptim
hbv
e
antigen
hbeag
approxim
greater
wide
type
hbeag
gene
dosag
foreign
protein
great
impact
recombin
protein
product
screen
transform
contain
multipl
integr
event
import
achiev
high
level
recombin
protein
report
increas
gene
copi
number
recombin
hemagglutinin
ha
swine
origin
influenza
viru
enhanc
protein
express
level
recombin
protein
effici
secret
medium
endoplasm
reticulum
er
retent
highlevel
product
problem
translat
secretori
protein
follow
transloc
er
mediat
secret
signal
peptid
recombin
protein
fail
fold
nativ
state
protein
express
exce
fold
capac
er
unfold
aggreg
protein
may
start
accumul
er
thu
trigger
unfold
protein
respons
upr
erassoci
degrad
erad
pathway
er
contain
sever
chaperon
foldas
member
bip
calnexin
calreticulin
protein
disulfid
isomeras
pdi
cooverexpress
er
protein
target
protein
shown
significantli
improv
yield
recombin
protein
er
stress
protein
fold
affect
redox
state
er
cytosol
redox
balanc
impact
protein
fold
alter
level
redox
activ
enzym
antioxid
transcript
factor
glutathion
peroxidas
gpx
yield
foreign
protein
could
improv
one
major
problem
hinder
effect
secret
purif
heterolog
protein
p
pastori
degrad
recombin
protein
hostspecif
proteas
high
level
host
proteas
present
p
pastori
readili
induc
environment
stress
multipl
approach
implement
solv
problem
addit
proteas
inhibitor
pepton
casamino
acid
specif
amino
acid
optim
cultiv
condit
ph
temperatur
medium
composit
nitrogen
carbon
sourc
approach
usual
limit
effect
genet
manipul
host
proteas
effici
reduc
degrad
recombin
protein
therefor
mani
proteasedefici
yeast
strain
develop
due
avail
genom
sequenc
p
pastori
detail
understand
yeast
physiolog
genet
regul
develop
rapidli
facilit
develop
improv
strain
custom
properti
high
yield
product
recombin
protein
furthermor
genet
engin
p
pastori
util
optim
hostcel
background
order
produc
protein
proper
posttransl
modif
optim
cultur
condit
induct
protocol
also
essenti
increas
recombin
protein
yield
variou
condit
induct
paramet
includ
media
composit
temperatur
ph
methanol
concentr
induct
time
consid
design
optim
product
system
achiev
high
yield
desir
protein
activ
form
p
pastori
shown
excel
capac
produc
subunit
vaccin
candid
suffici
quantiti
requir
viabl
industri
applic
high
puriti
recombin
vaccin
candid
less
contamin
protein
could
obtain
p
pastori
strong
immunogen
characterist
improv
stabil
due
proper
posttransl
modif
better
protein
fold
perform
p
pastori
make
host
superior
express
system
p
pastori
becom
frequent
use
system
heterolog
protein
product
recent
approv
biopharmaceut
produc
p
pastori
make
system
safe
suitabl
product
vaccin
candid
thu
assum
biopharmaceut
applic
p
pastori
system
rapidli
increas
adopt
place
among
top
product
system
besid
e
coli
cho
cell
advanc
strain
process
develop
strongli
increas
product
p
pastori
system
furthermor
achiev
engin
glycosyl
fold
assembl
complex
protein
p
pastori
expand
rang
target
protein
includ
current
produc
express
system
p
pastori
develop
one
power
popular
system
product
recombin
protein
commerci
interest
offer
variou
advantag
host
system
includ
stabl
express
highlevel
product
low
cost
eas
genet
manipul
importantli
p
pastori
capabl
secret
heterolog
protein
nativ
conform
structur
strong
immunogen
featur
along
improv
genet
manipul
express
purpos
made
p
pastori
import
express
system
product
subunit
vaccin
potenti
conflict
interest
disclos
work
fund
promot
research
fund
excel
young
middleag
scientist
shandong
provinc
